Molecular Medicine: Targeting Patients with the Right Treatment

Allison Connolly, Biotechnology Reporter for the Boston Business Journal, talks to Dr Jeffrey Ross, Vice President for Molecular Medicine at Millennium Pharmaceuticals Inc


Dr Jeffrey Ross graduated from the Oberlin College and Buffalo School of Medicine. He was certified by the American Board of Pathology in 1974. Following this, Dr Ross served as Chief of Pathology at the Moncrief United States Army Hospital and was Professor at both Harvard Medical School and Massachusetts General Hospital.

In 1989 he became Professor and Chairman at the Albany Medical College and Pathologist-in-Chief at the Albany Medical Center Hospital. Dr Ross is Associate Editor for Basic Science of the American Journal of Clinical Pathology. He has served as Commissioner for graduate medical education of the American Society of Clinical Pathologists and serves on the scientific advisory boards of the Welch-Allyn Corporation, Tripath Oncology Inc and US Labs Inc.

In 1999 Dr Ross was named Scientific Fellow and Head of Molecular Pathology at Millennium Pharmaceuticals Inc, and became Vice President for Molecular Medicine in 2001.